30 closest matches · ranked by relevance
Pain Control After Functional Endoscopic Sinus Surgery and Septoplasty
Primary: Pain Score as Assessed by a 100mm Visual Analogue Scale (VAS) — 30.2; 40.7 units on a scale
Osseointegrated Dental Implantation · Pain, Acute
Primary: Pain Intensity Scores on Numeric Pain Intensity Scale 0-6 Hours — 1; 3 score on a scale — p=<0.05
Hematology
Primary: Inhibition of Serum Thromboxane B2 (TXB2) on Day 16 at 24 Hour Post IR ASA 81 mg Administration — 93.09; 87.71; 92.87; 98.72 percentage
Fractures
Primary: Compare the Time to Union of Fractures and Osteotomies in Skeletally Immature Patients Administered NSAIDs for Pain Control, Versus Those Administered Acetaminophen for…
Inflammation · Cancer · Pain
Primary: Change in Breast Density Measured as Fat to Water Ratio by Magnetic Resonance Imaging — -9.8; -3.6 percent change in breast density — p=<0.05
Ulcer
Primary: Number of Participants Who Develop Endoscopically-diagnosed Gastric Ulcers — 55; 52 participants — p=<0.0001
Rhinoplasty · Non-steroidal Ant Inflammatory Drugs · Opioid Use
Primary: Average Pain Score — 2.54; 3.14 score on a scale
NSAID-induced Gastroduodenal Injury · Ulcers · Rheumatoid Arthritis
Primary: Number of Participants With Gastric Ulcers — 7; 5; 7; 4 Participants
Osteoarthritis Knee Pain
Primary: Change From Baseline in the Weekly Mean of the 24-Hour Average Pain Score at 8 Weeks — -1.55; -2.46 units on a scale — p=<0.001
Hypertension, Pregnancy-Induced
Primary: Average Mean Arterial Blood Pressure- Mild Group — 93; 93 mmHg
Gastric Ulcer
Primary: Number of Participants With Gastric Ulcer Confirmed by Endoscopy — 15; 51 Participants — p=0.001
Back Pain Without Radiation · Low Back Pain
Primary: Change From Baseline to Day 5 in Functional Impairment — 11.9; 9.4; 10.9 score on a scale
Gastric Ulcer
Primary: Number of Participants With Gastric Ulcer Confirmed by Endoscopy — 9; 50 Participants — p=0.001
Pain
Primary: Time-Weighted Sum of Pain Intensity Difference Score From Baseline (0 Hour) to 6 Hours (SPID 0-6) — 2.36; 25.59; 30.28; 33.77 Units on a scale
Pain
Primary: Time Weighted Sum of Pain Intensity Difference Score From Baseline (0 Hour) to 12 Hours (SPID 0-12) — 5.59; 37.08; 46.98; 52.45 Units on a scale — p=<0.001
Intravitreal Injections · IVI
Primary: McGill Pain Questionnaire (SF-MPQ) Scores at Baseline — 0.62; 0.93; 0.53 score on a scale
Pain
Primary: Use Days With One or More Misuse Occasions — 2112; 294 days
Immune System and Related Disorders
Primary: Level of Pain — .39; .19; .14; .56 units on a scale
Diabetic Macular Edema
Primary: Mean Change in Optical Coherence Tomography Measure Retinal Volume, mm3 — 0.02; -0.03 mm3
Ankle Sprain
Primary: Change From Baseline at Day 3 in Pain Visual Analog Scale (VAS) - Per Protocol Population — -44.88; -40.76 scores on a scale
Pain, Postoperative
Primary: Time to First Use of Rescue Medication — 1.22; 1.22; 1.18; 11.017 hours — p=<0.001
Pain, Postoperative
Primary: Pain as Assessed by a Visual Analogue Scale (VAS) — 4; 2.33 score on a scale
Toothache
Primary: Summed Pain Intensity Difference (SPID) — 25.9; -3.1; 8.8; -1.0 units on a scale — p=<0.001
Disorder of Urinary Stent · Ureteral Spasm · Ureteropelvic Junction Obstruction
Primary: Incidence of Post-operative Severe Pain (Pain Score ≥ 7) — 2; 1 Participants
Contraception
Primary: Pain at Time of IUD Insertion Using a 10 cm (100 mm) Visual Analog Scale (VAS) — 69; 66 units on a scale
Menorrhagia
Primary: Mean Days of Bleeding and Spotting, Spotting Only and Bleeding Only for the 84 Day Treatment Cycles and Last 28 Day Post-treatment Cycle — 29.2; 23.0; 9.3; 9.6 days…
Acute Kidney Injury · Exercise-associated Hyponatremia · Perceived Exertion
Primary: Acute Kidney Injury — 16; 22 Participants
Altitude Sickness
Primary: Acute Mountain Sickness — 19; 26 Participants
Pain
Primary: Time-weighted Sum of Pain Intensity Difference Scores on 11-Point Numerical Scale From 0 to 24 Hours Post-dose (SPID11 [0-24]) — -8.13; 64.76 units on a Scale — p=<0.001
Pain
Primary: Percentage of Subjects With Any Adverse Event for Those Subjects Who Were Randomized and Took at Least One Dose of Investigational Product — 39.6; 45.0 Percentage of…